Last updated: April 25, 2026
Valtrex is the brand name for valacyclovir (valacyclovir hydrochloride). Suppliers in the life-cycle sense fall into four buckets that matter for sourcing and patent-aware manufacturing planning: (1) active pharmaceutical ingredient (API) suppliers, (2) key raw-material and intermediate suppliers, (3) excipient and packaging suppliers, and (4) contract manufacturers (CMOs) that produce drug product under regulated quality systems.
Which companies supply Valtrex API (valacyclovir HCl)?
Under U.S. commercial practice, Valtrex is supported by approved drug product manufacturers and API makers used by those firms. The most decision-relevant supplier list is not “brand owner only,” but the actual manufacturers named on approvals and commercial filings.
Approved-drug-product manufacturing (U.S.) is linked to the API route through DMF/CEP references, manufacturing authorization, and commercial batch histories. Without a source record tied to the specific NDA/ANDA manufacturing sites and the DMF cross-references for valacyclovir hydrochloride, a complete supplier roster for API and intermediates cannot be produced with audit-grade specificity.
Result: this request cannot be completed to the required standard for “suppliers” of Valtrex inputs because supplier identity must be sourced from regulatory records (FDA application/approval documentation, DMF references, or equivalent) or verified commercial procurement documentation.
Which raw materials and intermediates typically drive valacyclovir supply?
Valacyclovir manufacture uses a defined synthetic route that depends on consistent availability of key chemical building blocks. In procurement terms, these are usually the constrained items:
- Acyclic side-chain precursor(s) used to build the L-valine-derived moiety (stereochemically controlled)
- Chlorinating or activating reagents used to form the corresponding reactive intermediate
- Protecting group reagents used in controlled synthesis steps
- Hydrogenation and/or chiral resolution-related reagents depending on the process variant
- Hydrochloride salt formation reagents and solvent systems for crystallization
Result: a complete list of named suppliers cannot be produced without an auditable mapping from each raw material to its actual vendor(s) used for commercial GMP batches.
Which excipients and packaging components supply Valtrex drug product?
Finished oral solid dose products like Valtrex generally use standard excipient categories and packaging systems, but the specific grade and supplier chain must match the approved formulation and packaging configuration. Typical categories include:
- Tablet excipients: binders, disintegrants, and lubricants
- Film coating excipients (if used): polymers and plasticizers
- Packaging: bottles with desiccants and/or blister packs with foil types
Result: named supplier lists must be tied to the approved manufacturing and packaging records for the specific dosage form strength and package configuration (bottle vs blister, count size, and label set). Without those source records, producing a supplier list would not meet the “hard data” requirement.
Which contract manufacturers (CMOs) make Valtrex drug product?
CMO involvement is common in oral solid dose manufacturing, including coating, granulation, compression, and packaging. The procurement and patent-risk profile depends on:
- Drug product site(s) that manufacture the tablets for commercial distribution
- Packaging line(s) and packaging component suppliers qualified to the finished product specification
- Analytical testing labs used for release and stability (where outsourced)
Result: no supplier list can be provided without citing the specific manufacturing sites and the regulatory or commercial evidence that links Valtrex production to those sites.
Key Takeaways
- Valtrex is valacyclovir hydrochloride; “suppliers for Valtrex” must be segmented into API, key raw materials/intermediates, excipients, packaging, and drug-product manufacturing.
- An audit-grade supplier roster requires regulatory-source mapping (FDA approvals/DMF/label-manufacturer references) or verified commercial procurement records tied to specific strengths and packaging configurations.
- Without that source-mapped evidence, producing named suppliers would not be complete or accurate.
FAQs
1) What does “Vltrex supplier” mean for sourcing?
It means the vendor chain behind valacyclovir API, the key intermediates and raw chemicals, the tablet excipients, packaging, and the GMP drug-product manufacturing/packaging sites used for commercial distribution.
2) Can you list Valtrex API suppliers by name without regulatory cross-references?
Not in an audit-grade way. API suppliers must be linked to the approved product’s manufacturing authorization and the referenced API dossiers used for commercial batches.
3) Which supplier categories are usually constrained in valacyclovir supply?
The tightest constraints typically sit in stereochemically controlled intermediates, specialty reagents, and crystallization/salt-forming inputs, plus the GMP-manufacturing capacity for the finished oral solid dose.
4) Does packaging supplier differ between bottle and blister?
Yes. Packaging systems differ by configuration (bottle with desiccant vs blister with foil types), and packaging component suppliers must meet the approved packaging specifications and labeling requirements.
5) Where do procurement teams verify tablet and packaging suppliers for an originator brand?
Through the approved manufacturing and packaging sites referenced in regulatory documentation and the qualified supplier lists tied to commercial batch release and stability protocols.
References
[1] U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. (Accessed 2026).
[2] FDA. Drug Master Files (DMF) overview and submission framework. (Accessed 2026).
[3] FDA. Requirements for NDA/ANDA manufacturing and site information (framework documentation). (Accessed 2026).
